KWF
Lead4Life
12:00 noon; full-proposal phase only (matchmaking phase precedes)
Last verified:
Details
| Funder | KWF |
| Budget | €0.5M–€2M per project (total PPP subsidy budget €5M) |
| Deadline | 22 September 2026 |
| Duration | Up to 4 years |
| Consortium | Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory |
| Application | 2-stage: matchmaking phase → full proposal |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Health~Holland PPP programme (KWF, NRG PALLAS, FAST, Oncode Institute) focused on lead-212 radiopharmaceuticals for cancer treatment. Proposals must address Pb-212 production/supply chain or enabling technologies for clinical introduction. Private-party co-investment required; projects must comply with Health~Holland PPP requirements and TKI-LSH budget rules. Dutch Summary reviewed by Patient Advisory Committee.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
Boost
Deadline: 7 Jul 2026~€150,000 per project, including VATPipeline
Deadline: 7 Jul 2026€1M–€2.5M (Phase I/I-II); €1M–€5M (Phase II/III)KWF Pipeline Call 2026
Deadline: 7 Jul 2026€1M-€5MExploration Call 2026-3
Deadline: 1 Sept 2026Proof of Concept
Deadline: 22 Sept 2026Up to €150,000 incl. VAT
Browse Related
Could Lead4Life be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →